GlycoMimetics Inc (NASDAQ:GLYC)

8.65
Delayed Data
As of Apr 20
 +0.07 / +0.82%
Today’s Change
6.02
Today|||52-Week Range
14.55
+20.14%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close8.58
Today’s open8.59
Day’s range8.56 - 8.77
Volume17,623
Average volume (3 months)28,384
Market cap$163.0M
Dividend yield--
Data as of 4:00pm ET, 04/20/2015

Growth & Valuation

Earnings growth (last year)-5.26%
Earnings growth (this year)+50.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+276.37%
P/E ratioNM
Price/Sales8.84
Price/Book3.20

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc-0.19-3.12%
ARGSArgos Therapeutics I...+0.06+0.71%
PVCTProvectus Biopharmac...+0.02+2.47%
CRMECardiome Pharma Corp+0.26+2.74%
Data as of 4:00pm ET, 04/20/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.29
Annual revenue (last year)$15.0M
Annual profit (last year)-$11.1M
Net profit margin-74.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer &
Head-Media Relations
Brian M. Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers